Table VI.
Changes in HGB concentration, RBC and LDH activity with respect to degree of PVL CSA reduction
| Variable | Reduction of CSA < 90% N = 16 |
Reduction of CSA ≥ 90% N = 59 |
P-value |
|---|---|---|---|
| ΔHGBdischarge – 1 month [g/dl] | 0.7 ±1.1 0.7 (0.2–0.9) |
1.3 ±1.0 1.2 (0.5–2.0) |
0.0365 |
| ΔHGBbaseline – 6 months [g/dl] | 0.0 ±1.8 | 1.6 ±1.6 | 0.0020 |
| ΔRBCCdischarge – 1 month [M/mm3] | 0.2 ±0.3 0.1 (–0.1 – 0.4) |
0.5 ±0.3 0.5 (0.2–0.7) |
0.0007 |
| ΔRBCCbaseline – 6 months [M/mm3] | –0.1 ±0.7 0.0 (–0.9 – 0.4) |
0.6 ±0.5 0.6 (0.2–0.9) |
0.0003 |
| ΔLDHdischarge – 1 month [IU/l] | 48.9 ±260.5 38.0 (36.8–108.0) |
8.9 ±181.4 3.0 (–88.0 – 73.0) |
0.3512 |
| ΔLDHbaseline – 6 months [IU/l] | –164.9 ±577.3 –6.0 (–290.0 – 117.0) |
–296.9 ±508.1 –173.0 (–487.0 – 28.0) |
0.2547 |